PAPER
SEARCH RESULTS
329938 RESULTS
PAPER de Hoyos-Alonso MC, Tapias-Merino E, Meseguer Barros CM, Sánchez-Martínez M, Otero A
Consumption trends for specific drugs used to treat dementia in the region of Madrid (Spain) from 2002 to 2012.
Neurologia. 2014 Apr 3; PubMed: 24704249PAPER Chen S, Gao S, Cheng D, Huang J
The characterization and comparison of amyloidogenic segments and non-amyloidogenic segments shed light on amyloid formation.
Biochem Biophys Res Commun. 2014 May 2;447(2):255-62. Epub 2014 Apr 1 PubMed: 24704202PAPER Lee HM, Kwon KY, Kim MJ, Jang JW, Suh SI, Koh SB, Kim JH
Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia.
Parkinsonism Relat Disord. 2014 Jun;20(6):622-6. Epub 2014 Mar 20 PubMed: 24703894PAPER Raskind MA, Wang LY
Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
Int Psychogeriatr. 2014 Jun;26(6):879-83. Epub 2014 Apr 4 PubMed: 24703502PAPER Camilleri A, Vassallo N
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease.
CNS Neurosci Ther. 2014 Apr 7; PubMed: 24703487PAPER Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM, URICO-ICTUS Investigators
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
Lancet Neurol. 2014 May;13(5):453-60. Epub 2014 Apr 2 PubMed: 24703208PAPER Zhang J, Saur T, Duke AN, Grant SG, Platt DM, Rowlett JK, Isacson O, Yao WD
Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95.
J Neurogenet. 2014 Mar-Jun;28(1-2):98-111. Epub 2014 Apr 22 PubMed: 24702501PAPER Mignarri A, Battistini S, Tomai Pitinca ML, Monti L, Burroni L, Ginanneschi F, Ricci C, Bavazzano A, Federico A, Restagno G, Dotti MT
Double trouble? Progranulin mutation and C9ORF72 repeat expansion in a case of primary non-fluent aphasia.
J Neurol Sci. 2014 Jun 15;341(1-2):176-8. Epub 2014 Mar 19 PubMed: 24703252PAPER Butland SL, Sanders SS, Schmidt ME, Riechers SP, Lin DT, Martin DD, Vaid K, Graham RK, Singaraja RR, Wanker EE, Conibear E, Hayden MR
The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease.
Hum Mol Genet. 2014 Aug 1;23(15):4142-60. Epub 2014 Apr 4 PubMed: 24705354PAPER Wan W, Stubbs G
Fungal prion HET-s as a model for structural complexity and self-propagation in prions.
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5201-6. Epub 2014 Mar 24 PubMed: 24706820PAPER Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM, NET-PD Investigators
Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
JAMA Neurol. 2014 Jun;71(6):710-6. PubMed: 24711047PAPER Schwarz ST, Afzal M, Morgan PS, Bajaj N, Gowland PA, Auer DP
The 'swallow tail' appearance of the healthy nigrosome- a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.
PLoS One. 2014;9(4):e93814. Epub 2014 Apr 7 PubMed: 24710392PAPER Yu X, Wang F, Zhang JP
Meta analysis of the association of rs7702187 SNP in SEMA5A gene with risk of Parkinson's disease.
Eur Rev Med Pharmacol Sci. 2014;18(6):900-4. PubMed: 24706317PAPER Ferguson MC, Nayyar T, Ansah TA
Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease.
Neurochem Int. 2014 May;71:36-46. Epub 2014 Apr 4 PubMed: 24704796Current Filters
No filters selected